Back
Korean Biohealth R&BD Night
Biopharma Dealmaking: Buy-Side and Sell-Side Perspectives
Sep 24, 2026, 6:00 PM - 7:20 PM EDT
at Santo Domingo Room

This session offers a two-sided look at the negotiation table of biotech deals, followed by a panel unpacking how buy-side and sell-side priorities actually meet in practice. Attendees will first hear the buy-side perspective on evaluating and pursuing deals, followed by the sell-side view from Seokwon Ham (TXINNO Bioscience). The session closes with a panel discussion featuring Taewon Yoon (Yuhan USA) and Sangyeul Han (Ingenia Therapeutics), who will unpack the practical realities of navigating biopharma dealmaking from both directions.

  • 6:00 PM — Biopharma Deal Insights: The Buy-Side Perspective — TBD

  • 6:30 PM — Biopharma Deal Insights: The Sell-Side Perspective — Seokwon Ham (TXINNO Bioscience)

  • 7:00 PM — Panel Discussion: Navigating Biopharma Deals from Both Sides — Taewon Yoon (Yuhan USA), Sangyeul Han (Ingenia Therapeutics), Seokwon Ham (TXINNO Bioscience)